AbCellera Biologics Inc.
ABCL
$4.24
-$0.23-5.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 605.27M | 625.61M | 643.14M | 670.36M | 698.02M |
| Total Receivables | 126.61M | 92.13M | 63.24M | 67.70M | 68.78M |
| Inventory | -- | -- | -- | -- | 738.00K |
| Prepaid Expenses | 8.10M | 8.63M | 11.51M | 8.50M | 21.41M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 25.00M | 25.00M | 25.00M | 25.00M | 25.00M |
| Total Current Assets | 764.98M | 751.37M | 742.88M | 771.55M | 813.95M |
|
|
|||||
| Total Current Assets | 764.98M | 751.37M | 742.88M | 771.55M | 813.95M |
| Net Property, Plant & Equipment | 347.10M | 340.43M | 331.26M | 318.88M | 306.08M |
| Long-term Investments | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Goodwill | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Total Other Intangibles | 41.19M | 42.11M | 52.58M | 85.66M | 118.74M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 61.56M | 96.54M | 134.22M | 80.21M | 104.93M |
| Total Assets | 1.34B | 1.36B | 1.39B | 1.41B | 1.46B |
|
|
|||||
| Total Accounts Payable | 32.80M | 34.35M | 34.80M | 26.59M | 26.91M |
| Total Accrued Expenses | 3.19M | 8.38M | 5.99M | 4.36M | 2.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.64M | 4.62M | 5.13M | 5.60M | 5.53M |
| Total Finance Division Other Current Liabilities | 34.77M | 29.27M | 33.66M | 33.84M | 69.60M |
| Total Other Current Liabilities | 34.77M | 29.27M | 33.66M | 33.84M | 69.60M |
| Total Current Liabilities | 75.40M | 76.61M | 79.57M | 70.38M | 104.88M |
|
|
|||||
| Total Current Liabilities | 75.40M | 76.61M | 79.57M | 70.38M | 104.88M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 63.21M | 60.74M | 66.27M | 66.45M | 68.08M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 182.62M | 167.11M | 168.89M | 164.68M | 160.22M |
| Total Liabilities | 321.23M | 304.47M | 314.73M | 301.51M | 333.18M |
|
|
|||||
| Common Stock & APIC | 958.67M | 943.53M | 928.19M | 910.79M | 892.55M |
| Retained Earnings | 71.31M | 116.93M | 151.14M | 202.25M | 239.18M |
| Treasury Stock & Other | -7.00M | -4.38M | -1.23M | -2.07M | -1.82M |
| Total Common Equity | 1.02B | 1.06B | 1.08B | 1.11B | 1.13B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.02B | 1.06B | 1.08B | 1.11B | 1.13B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.02B | 1.06B | 1.08B | 1.11B | 1.13B |
|
|
|||||